Flu, Human
8 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Tolerability, Safety and Immunogenicity Trial of the Flu-M® Inactivated Vaccine in Volunteers Aged 18 to 60 Years (NCT05312294) | St. Petersburg Research Institute of Vaccines and Sera | 2020-12-07 |
| Persuasion in Medicine: Experimental Evidence on Sender and Signal Effects (NCT04160975) | Harvard University | 2019-12-20 |
| Factors Influencing Flu Vaccination in Primary Health Care (NCT04097197) | Agrupamento de Centros de Saúde de Dão Lafões | 2019-10-14 |
| Volatiles in Breath and Headspace Analysis - Diagnostic Markers (NCT03228095) | University of Latvia | 2017-07-24 |
| Safety and Immunogenicity of Two Doses of aH5N1 Vaccine in Adult and Elderly Subjects With and Without Immunosuppressive Conditions *aH5N1:Monovalent H5N1 Influenza Vaccine (NCT02107807) | Seqirus | 2014-04-01 |
| Study of the Safety, Tolerability and Immunogenicity of an Intranasal Influenza Vaccine Administered to Healthy Adults (NCT03293732) | Advagene Biopharma Co. Ltd. | 2012-11-28 |
Track Flu, Human automatically
Every clearance here is in the API, with alerts when new ones post.